Testing tissue monitoring during brain tumor surgery
Part of Cancer clinical trials.
This study looks at a new way to check brain tumor tissue during surgery. If you are having surgery for an aggressive brain tumor, the doctors want to see if this monitoring technique is practical and helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having surgery to remove a suspected high-grade glioma (an aggressive brain tumor).
- You are 18 years or older.
- You can provide written consent to join the study.
- You are not pregnant, a prisoner, or someone with an intellectual disability.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to measure fluorescence in fluid suctioned from the brain during glioma surgery. It may help surgeons better identify tumor tissue.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
This early-stage study measures electrical brain activity during brain tumor surgery to see if it can predict tumor return or progression. You may be offered the additional measurements while your surgeon removes a suspected or known high-grade glioma.
This trial tests a special fluorescent dye (FG001) that helps surgeons see and remove high-grade brain tumors more completely during surgery. The dye is injected before surgery and glows under special light, potentially helping surgeons remove more tumor tissue safely.
This trial studies whether a blood test can track the progress of a type of brain tumor called a grade 4 diffuse glioma. It may offer a less invasive way to monitor these tumors after surgery.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
Hear when a new High Grade Gliomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.